Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Turnstone Biologics is a biotechnology company focused on developing cancer immunotherapies, particularly tumor-infiltrating lymphocyte (TIL) and oncolytic viral therapies. Its pipeline includes innovative TIL and viral-based treatments targeting solid tumors. The company owns extensive intellectual property and collaborates with research institutions. It aims to advance immuno-oncology solutions, seeking regulatory approval and strategic transactions to maximize value in the cancer treatment market.
This description was generated via AI from an annual report. Updated about 1 year ago.